Description

Technical Parameters

Introduction

peptides

product-1400-1400

Products Description

**A systematic review of AICAR peptides: classification, physicochemical properties and their potential applications**

AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) is a widely studied nucleotide analogue, known for its ability to activate AMPK (adenosine monophosphate-activated protein kinase), and has attracted much attention in metabolic regulation, sports science and disease treatment. In recent years, with the rise of peptide drugs, the concept of "AICAR peptide" has gradually entered the research field, which usually refers to a complex formed by combining AICAR with a peptide chain through chemical modification, or a mimetic peptide designed based on AICAR function. This article systematically sorts out the classification, physicochemical properties, biological activity and potential applications of AICAR peptides, in order to provide a reference for related fields.

### **1. Classification and functional characteristics of AICAR peptides**

Based on structural design and functional differences, AICAR peptides can be divided into the following four categories:

#### **1. Carrier-coupled AICAR peptides**

**Structural features**: AICAR molecules are connected to targeting peptides or penetrating peptides (such as cell-penetrating peptides CPP) through covalent bonds (such as ester bonds, amide bonds) to form a prodrug form.

**Advantages**:

- Improve bioavailability: overcome the problem of poor membrane permeability when AICAR is used alone.

- Targeted delivery: achieve targeted enrichment of tumors or specific tissues by coupling targeting peptides (such as RGD peptides).

- Extend half-life: Peptide chains can reduce rapid renal clearance and increase the duration of drug efficacy.

**Physical and chemical properties**:

- Molecular weight: usually 1-3 kDa (depending on the length of the peptide chain).

- Solubility: Most are water-soluble, but hydrophobic modification may require a cosolvent (such as DMSO).

- Color: Lyophilized powder is white or off-white, and the solution is colorless and transparent.

#### **2. AMPK Activation Mimetic Peptide**

**Structural Features**: Through computer-aided design or phage display technology, short peptide sequences (usually 8-15 amino acids) that simulate AICAR to activate AMPK are screened.

**Advantages**:

- High specificity: Avoid off-target effects of AICAR that are not AMPK-dependent.

- Enhanced stability: Better resistance to enzymatic hydrolysis than natural AICAR.

**Physical and Chemical Properties**:

- Molecular weight: about 800-1500 Da.

- Thermal stability: Most of them remain active below 60°C, and the freeze-dried shelf life is long.

- Color: White loose powder after freeze-drying.

#### **3. Metabolic Regulation Peptide Complex**

**Structural Features**: Combine AICAR with metabolism-related peptides (such as glucagon-like peptide-1, GLP-1) to form a bifunctional molecule.

**Advantages**:

- Synergistic effect: Regulate energy metabolism and insulin sensitivity at the same time.

- Reduce side effects: achieve multi-pathway regulation at low doses.

**Physical and chemical properties**:

- Molecular weight: 3-5 kDa, may form dimers.

- Solubility: requires buffer (such as PBS) to dissolve, high pH sensitivity.

#### **4. Nanoparticle-loaded AICAR peptide**

** Structural features**: AICAR is encapsulated in peptide-based nanocarriers (such as self-assembled lipopeptide particles) to achieve controlled release.

**Advantages**:

- Sustained release effect: prolong drug action time and reduce dosing frequency.

- Protect active ingredients: avoid gastrointestinal degradation, suitable for oral delivery.

**Physical and chemical properties**:

- Particle size: 50-200 nm, dynamic light scattering shows uniform distribution.

- Surface charge: Zeta potential ±10-30 mV, dependent on peptide sequence modification.

- Color: Colloidal solution is opalescent or light blue (Tyndall effect).

### **2. Analysis of the physicochemical properties of AICAR peptide**

#### **1. Solubility and stability**

- **Water solubility**: Unmodified AICAR peptide is easily soluble in water (>50 mg/mL), and hydrophobic modification requires the addition of surfactants.

- **pH stability**: Optimum pH 6-8, easy to hydrolyze or aggregate under strong acid/base conditions.

- **Thermal stability**: Short-term tolerance to 40℃ (activity retention>90% within 24 hours), long-term storage at -20℃.

#### **2. Spectral characteristics**

- **Ultraviolet absorption**: AICAR has a characteristic absorption peak at 260 nm, which may be red-shifted to 270-280 nm after coupling with peptide chains.

- **Fluorescent labeling**: Some studies use FITC labeling, with excitation/emission wavelengths of 490/520 nm, to track intracellular distribution.

#### **3. Color and morphology**

- **Solid**: Freeze-dried powder is mostly white or light yellow (with protective agent).

- **Liquid**: Clear and transparent (except nanoformulations), high concentration may show slight opalescence.

### **3. Application potential of AICAR peptide**

#### **1. Treatment of metabolic diseases**

- **Diabetes**: Promote glucose uptake through AMPK activation, and enhance pancreatic islet function in combination with GLP-1 peptide.

- **Obesity**: Stimulate fat oxidation and inhibit lipid synthesis.

#### **2. Enhanced sports performance**

- Improve muscle endurance: simulate the "sports molecule" effect and increase mitochondrial biosynthesis.

#### **3. Anti-aging research**

- Activate the autophagy pathway: remove senescent cells and delay tissue degeneration.

#### **4. Tumor treatment**

- Targeted delivery AICAR peptide can inhibit tumor metabolic reprogramming and enhance chemotherapy sensitivity.

### **4. Challenges and future directions**

- **Synthesis cost**: The complex coupling process leads to high production costs, and an efficient solid-phase synthesis strategy needs to be developed.

- **Safety assessment**: Long-term toxicity and immunogenicity need to be further verified.

- **Delivery system optimization**: Explore oral or transdermal dosage forms to improve patient compliance.

**Conclusion**

AICAR peptides show the potential to regulate metabolism in multiple dimensions by combining the advantages of nucleotides and peptides. With the advancement of precision modification technology, it is expected to play an important role in personalized medicine and regenerative medicine. Future research needs to focus on structural optimization and clinical transformation to overcome existing limitations and release its full value.